Artemisinin-resistant malaria: research challenges, opportunities, and public health implications
about
Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient dataRecent advances in malaria drug discoveryReview of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop reportFluorine Modulates Species Selectivity in the Triazolopyrimidine Class of Plasmodium falciparum Dihydroorotate Dehydrogenase InhibitorsA Systematic Review of Anti-malarial Properties, Immunosuppressive Properties, Anti-inflammatory Properties, and Anti-cancer Properties of Artemisia AnnuaWomen's access and provider practices for the case management of malaria during pregnancy: a systematic review and meta-analysisThe Cambodia Research Consortium: expediting research for malaria elimination with the emergency response to artemisinin resistance framework.Monitoring parasite diversity for malaria elimination in sub-Saharan AfricaAlternatively spliced transcripts and novel pseudogenes of the Plasmodium falciparum resistance-associated locus pfcrt detected in East African malaria patientsCharacterization of the differences in the cyclopiazonic acid binding mode to mammalian and P. Falciparum Ca2+ pumps: a computational studyThe clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread.Emerging artemisinin resistance in the border areas of Thailand.Antiparasitic chemotherapy: from genomes to mechanisms.Allelic Diversity and Geographical Distribution of the Gene Encoding Plasmodium falciparum Merozoite Surface Protein-3 in Thailand.Malaria parasites produce volatile mosquito attractantsMobility dynamics of migrant workers and their socio-behavioral parameters related to malaria in Tier II, Artemisinin Resistance Containment Zone, Myanmar.Plant expression and characterization of the transmission-blocking vaccine candidate PfGAP50.Efficacy and Safety of Artesunate-Amodiaquine versus Artemether-Lumefantrine in the Treatment of Uncomplicated Plasmodium falciparum Malaria in Sentinel Sites across Côte d'Ivoire.How Robust Are Malaria Parasite Clearance Rates as Indicators of Drug Effectiveness and Resistance?Evaluation of Antiplasmodial activity of extracts and constituents from Ampelozizyphus amazonicus.Stearylamine Liposomal Delivery of Monensin in Combination with Free Artemisinin Eliminates Blood Stages of Plasmodium falciparum in Culture and P. berghei Infection in Murine Malaria.Plasmodium falciparum clearance rates in response to artesunate in Malian children with malaria: effect of acquired immunity.Early parasitological response following artemisinin-containing regimens: a critical review of the literature.Antiplasmodial activity of sesquiterpene lactones and a sucrose ester from Vernonia guineensis Benth. (Asteraceae).Analysis of the dose-dependent stage-specific in vitro efficacy of a multi-stage malaria vaccine candidate cocktail.Ahead of the curve: next generation estimators of drug resistance in malaria infections.Severe malaria in Battambang Referral Hospital, an area of multidrug resistance in Western-Cambodia: a retrospective analysis of cases from 2006-2009Global malaria connectivity through air travel.Quantifying the pharmacology of antimalarial drug combination therapy.Single-Dose Primaquine in a Preclinical Model of Glucose-6-Phosphate Dehydrogenase Deficiency: Implications for Use in Malaria Transmission-Blocking Programs.Lipid synthesis in protozoan parasites: a comparison between kinetoplastids and apicomplexansHousehold perceptions and subjective valuations of indoor residual spraying programmes to control malaria in northern Uganda.IDOMAL: the malaria ontology revisited.Dihydroartemisinin inhibits the mammalian target of rapamycin-mediated signaling pathways in tumor cellsSelection for chloroquine-sensitive Plasmodium falciparum by wild Anopheles arabiensis in Southern Zambia.Early parasite clearance following artemisinin-based combination therapy among Ugandan children with uncomplicated Plasmodium falciparum malariaEvidence for pyronaridine as a highly effective partner drug for treatment of artemisinin-resistant malaria in a rodent model.Diversity and population structure of Plasmodium falciparum in Thailand based on the spatial and temporal haplotype patterns of the C-terminal 19-kDa domain of merozoite surface protein-1Pharmacological considerations in the design of anti-malarial drug combination therapies - is matching half-lives enough?Novel anti-malarial combinations and their toxicity.
P2860
Q26783902-DAF9D811-5B82-41A6-B6CF-2D21C32FAB41Q27010534-C4AA6FD5-CD42-48E0-BFC8-8B4991D2CEF1Q27024922-39AE12E2-1DC9-4CEF-9B8B-11633F89D087Q27683656-F99DAD04-001E-4005-8059-93900929265AQ28072152-7FD90B95-A744-45AC-8B87-4A0FC274C870Q28541610-D013D42B-ACDE-4975-A467-778A51F78E64Q28603256-CEBAB24B-AD0F-4B80-8D2E-5F14E2D1882FQ28610494-0050C256-A571-49A7-9F01-C39E507F25F8Q28649722-4578FAF8-1387-4F73-B6E4-E1201DBEB6C8Q29048196-24D5C686-3E42-473C-90F5-EAAC8EFA57ACQ33655603-1B565993-83E6-4E80-A3E4-DACE825AEBB8Q34343530-FE12B56B-38AA-4833-A77F-DE129B5DE911Q35238319-EE365CC1-77C5-4F31-8328-A2BA9E07CD55Q35559584-4EED19E0-CD19-4786-ABD6-51B03556C2F0Q35677491-7A1037A7-2E0D-4098-BAEB-1D711732B776Q35775293-A8CB45FD-0197-4AAB-B0ED-98A5CB2985D4Q35857500-3A4387ED-F2FF-475D-B602-A72D82FB917CQ35996318-67D6B777-F19F-4A69-A640-770E1A6587C6Q36076111-4CDC1E0D-A6F8-4215-B9C1-1EEA817324DCQ36300737-E9419793-9766-4A94-A8CA-4A16D46B1CD7Q36644779-2196A45B-23F4-4F87-936F-C0E31AD2960EQ36796548-8854CABA-B3E9-41C6-9E6E-68A8B89C1BE4Q36831456-84ED423C-09F0-466A-B74B-6F759FB145B5Q36844124-4BB64847-DBF7-4C3E-8E87-A49160D3680BQ36906995-31391C53-C1EA-41AB-AC4E-F767EAA7F670Q36961003-AF8092D8-EC8C-4382-9E45-36D0F02FB383Q36975989-974B5EC2-F3D4-4F61-8CEE-3063207FC3DAQ37154025-5577423F-6BDF-40D2-9C29-8B12E5726F82Q37283299-875A0152-DA3D-4B1B-8A32-DFC64499BC54Q37287860-6A3A3FB7-BA05-47EF-A12A-0309E9608331Q37315680-23C78CC7-85CC-412F-AF8F-B6846D0FADF9Q37316103-868AAE58-4B80-4F11-9E64-2EEEF5449E22Q37359808-F4E497C6-A27B-495B-973B-7EB8D2564622Q37412018-0EA99F5F-637B-4592-989F-53994B92996DQ37425838-30416BF3-E269-4FD6-BF91-926882466503Q37539183-E6256387-C169-4E7E-999B-295F2253CCB5Q37544359-7B7495F8-5DCE-4DFF-A4FC-D3CFBBF4F87DQ37597218-A6ECA26F-F60B-4097-9E6C-ABF160C926A4Q37685088-F5564412-82E5-48C7-9284-3AE0847C05B2Q38203334-C8A76769-1809-45B1-B980-7B4BA8C8C94A
P2860
Artemisinin-resistant malaria: research challenges, opportunities, and public health implications
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Artemisinin-resistant malaria: ...... and public health implications
@ast
Artemisinin-resistant malaria: ...... and public health implications
@en
Artemisinin-resistant malaria: ...... and public health implications
@en-gb
Artemisinin-resistant malaria: ...... and public health implications
@nl
type
label
Artemisinin-resistant malaria: ...... and public health implications
@ast
Artemisinin-resistant malaria: ...... and public health implications
@en
Artemisinin-resistant malaria: ...... and public health implications
@en-gb
Artemisinin-resistant malaria: ...... and public health implications
@nl
prefLabel
Artemisinin-resistant malaria: ...... and public health implications
@ast
Artemisinin-resistant malaria: ...... and public health implications
@en
Artemisinin-resistant malaria: ...... and public health implications
@en-gb
Artemisinin-resistant malaria: ...... and public health implications
@nl
P2093
P2860
P50
P921
P3181
P1476
Artemisinin-resistant malaria: ...... and public health implications
@en
P2093
Gaurvika M L Nayyar
Joel G Breman
Jonathan L Vennerstrom
Rachel Hallett
Socheat Duong
Thomas E Wellems
P2860
P304
P3181
P356
10.4269/AJTMH.2012.12-0025
P407
P5008
P577
2012-08-01T00:00:00Z